{"count": 75, "results": [{"_id": "34444016", "pmid": 34444016, "pmcid": "PMC8394863", "title": "The Risk of Subsequent Miscarriage in Pregnant Women with Prior Polycystic Ovarian Syndrome: A Nationwide Population-Based Study", "journal": "Int J Environ Res Public Health", "authors": ["Pan ML", "Chen LR", "Chen KH"], "date": "2021-08-04T00:00:00Z", "doi": "10.3390/ijerph18168253", "meta_date_publication": "2021 Aug 4", "meta_volume": "18", "meta_issue": "16", "meta_pages": "", "score": 50269.883, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ might help to deal with these complex risk factors of @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriages@@@. ", "citations": {"NLM": "Pan ML, Chen LR, Chen KH. The Risk of Subsequent Miscarriage in Pregnant Women with Prior Polycystic Ovarian Syndrome: A Nationwide Population-Based Study Int J Environ Res Public Health. 2021 Aug 4;18(16):. PMID: 34444016", "BibTeX": "@article{34444016, title={The Risk of Subsequent Miscarriage in Pregnant Women with Prior Polycystic Ovarian Syndrome: A Nationwide Population-Based Study}, author={Pan ML and Chen LR and Chen KH}, journal={Int J Environ Res Public Health}, volume={18}, number={16}}"}}, {"_id": "34127011", "pmid": 34127011, "pmcid": "PMC8201680", "title": "The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis", "journal": "Reprod Biol Endocrinol", "authors": ["Yuan L", "Wu H", "Huang W", "Bi Y", "Qin A", "Yang Y"], "date": "2021-06-14T00:00:00Z", "doi": "10.1186/s12958-021-00772-7", "meta_date_publication": "2021 Jun 14", "meta_volume": "19", "meta_issue": "1", "meta_pages": "89", "score": 50265.37, "text_hl": "As expected, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also improved CPR and reduced @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@MR@@@ in @DISEASE_Primary_Ovarian_Insufficiency @DISEASE_MESH:D016649 @@@PCOS@@@ @SPECIES_9606 @@@patients@@@ as a result, clinical pregnancy rate (risk ratio [RR] = 1.26, 95% CI: 1.11-1.43, P = 0.0003), and @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriage@@@ rate (RR = 0.73, 95% CI:0.58-0.91, P = 0.006).", "citations": {"NLM": "Yuan L, Wu H, Huang W, Bi Y, Qin A, Yang Y. The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis Reprod Biol Endocrinol. 2021 Jun 14;19(1):89. PMID: 34127011", "BibTeX": "@article{34127011, title={The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis}, author={Yuan L and Wu H and Huang W and Bi Y and Qin A and Yang Y}, journal={Reprod Biol Endocrinol}, volume={19}, number={1}, pages={89}}"}}, {"_id": "40754172", "pmid": 40754172, "title": "Metformin for miscarriage prevention in women with polycystic ovary syndrome: a trustworthiness assessment revisited.", "journal": "Am J Obstet Gynecol", "authors": ["Cheshire J", "Garg A", "Smith P", "Devall AJ", "Coomarasamy A", "Dhillon-Smith RK"], "date": "2025-08-01T00:00:00Z", "doi": "10.1016/j.ajog.2025.07.042", "meta_date_publication": "2025 Aug 1", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50264.223, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriage@@@ prevention in @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@: a trustworthiness assessment revisited.", "citations": {"NLM": "Cheshire J, Garg A, Smith P, Devall AJ, Coomarasamy A, Dhillon-Smith RK. Metformin for miscarriage prevention in women with polycystic ovary syndrome: a trustworthiness assessment revisited. Am J Obstet Gynecol. 2025 Aug 1;():. PMID: 40754172", "BibTeX": "@article{40754172, title={Metformin for miscarriage prevention in women with polycystic ovary syndrome: a trustworthiness assessment revisited.}, author={Cheshire J and Garg A and Smith P and Devall AJ and Coomarasamy A and Dhillon-Smith RK}, journal={Am J Obstet Gynecol}}"}}, {"_id": "37409227", "pmid": 37409227, "pmcid": "PMC10319127", "title": "Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond", "journal": "Front Endocrinol (Lausanne)", "authors": ["Tosti G", "Barberio A", "Tartaglione L", "Rizzi A", "Di Leo M", "Viti L", "Sirico A", "De Carolis S", "Pontecorvi A", "Lanzone A", "Pitocco D"], "date": "2023-06-20T00:00:00Z", "doi": "10.3389/fendo.2023.1176623", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1176623", "score": 50260.3, "text_hl": "There was no evidence of a difference in live birth rate between the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and control groups (OR 1.23 95% CI 0.74-2.04), even dividing the two subgroups by BMI, or in @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriage@@@ rate (OR 0.58 95% CI 0.24-1.39).", "citations": {"NLM": "Tosti G, Barberio A, Tartaglione L, Rizzi A, Di Leo M, Viti L, Sirico A, De Carolis S, Pontecorvi A, Lanzone A, Pitocco D. Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond Front Endocrinol (Lausanne). 2023;14():1176623. PMID: 37409227", "BibTeX": "@article{37409227, title={Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond}, author={Tosti G and Barberio A and Tartaglione L and Rizzi A and Di Leo M and Viti L and Sirico A and De Carolis S and Pontecorvi A and Lanzone A and Pitocco D}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1176623}}"}}, {"_id": "36916886", "pmid": 36916886, "pmcid": "PMC10438881", "title": "Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS", "journal": "J Clin Endocrinol Metab", "authors": ["Ryssdal M", "Vanky E", "Stokkeland LMT", "Jarmund AH", "Steinkjer B", "Løvvik TS", "Madssen TS", "Iversen AC", "Giskeødegård GF"], "date": "2023-03-14T00:00:00Z", "doi": "10.1210/clinem/dgad145", "meta_date_publication": "2023 Mar 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50260.27, "text_hl": "We have previously shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduces the risk of @DISEASE_Premature_Birth @DISEASE_MESH:D047928 @@@preterm birth@@@ and @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@late miscarriage@@@ in pregnant @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, but an immunological involvement in this effect has not been determined.", "citations": {"NLM": "Ryssdal M, Vanky E, Stokkeland LMT, Jarmund AH, Steinkjer B, Løvvik TS, Madssen TS, Iversen AC, Giskeødegård GF. Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS J Clin Endocrinol Metab. 2023 Mar 14;():. PMID: 36916886", "BibTeX": "@article{36916886, title={Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS}, author={Ryssdal M and Vanky E and Stokkeland LMT and Jarmund AH and Steinkjer B and Løvvik TS and Madssen TS and Iversen AC and Giskeødegård GF}, journal={J Clin Endocrinol Metab}}"}}, {"_id": "32396212", "pmid": 32396212, "title": "Metformin therapy in pregnancy [Zastosowanie metforminy w ciazy].", "journal": "Endokrynol Pol", "authors": ["Krupej-Kędzierska J", "Cichocka E", "Kędzierski L", "Okopień B", "Gumprecht J"], "date": "2020-01-01T00:00:00Z", "doi": "10.5603/EP.a2020.0016", "meta_date_publication": "2020", "meta_volume": "71", "meta_issue": "2", "meta_pages": "184-195", "score": 50255.11, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ therapy in pregnancy [Zastosowanie metforminy w ciazy].", "citations": {"NLM": "Krupej-Kędzierska J, Cichocka E, Kędzierski L, Okopień B, Gumprecht J. Metformin therapy in pregnancy [Zastosowanie metforminy w ciazy]. Endokrynol Pol. 2020;71(2):184-195. PMID: 32396212", "BibTeX": "@article{32396212, title={Metformin therapy in pregnancy [Zastosowanie metforminy w ciazy].}, author={Krupej-Kędzierska J and Cichocka E and Kędzierski L and Okopień B and Gumprecht J}, journal={Endokrynol Pol}, volume={71}, number={2}, pages={184-195}}"}}, {"_id": "40473092", "pmid": 40473092, "title": "Preconception and first trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis.", "journal": "Am J Obstet Gynecol", "authors": ["Cheshire J", "Garg A", "Smith P", "Devall AJ", "Coomarasamy A", "Dhillon-Smith RK"], "date": "2025-06-03T00:00:00Z", "doi": "10.1016/j.ajog.2025.05.038", "meta_date_publication": "2025 Jun 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.855, "text_hl": "Indirect comparisons of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ continued through first trimester vs @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ stopped once pregnant consistently demonstrated a trend favouring the continuation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: clinical pregnancy OR 1.16 (95% CI 0.74-1.83), @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriage@@@ OR 0.44 (95% CI 0.17-1.16) and live birth OR 1.14 (95% CI 0.41-3.13). ", "citations": {"NLM": "Cheshire J, Garg A, Smith P, Devall AJ, Coomarasamy A, Dhillon-Smith RK. Preconception and first trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025 Jun 3;():. PMID: 40473092", "BibTeX": "@article{40473092, title={Preconception and first trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis.}, author={Cheshire J and Garg A and Smith P and Devall AJ and Coomarasamy A and Dhillon-Smith RK}, journal={Am J Obstet Gynecol}}"}}, {"_id": "33849126", "pmid": 33849126, "title": "Research progress of metformin in gestational diabetes mellitus: a narrative review.", "journal": "Ann Palliat Med", "authors": ["Ouyang H", "Al-Mureish A", "Wu N"], "date": "2021-03-01T00:00:00Z", "doi": "10.21037/apm-21-192", "meta_date_publication": "2021 Mar", "meta_volume": "10", "meta_issue": "3", "meta_pages": "3423-3437", "score": 50250.68, "text_hl": "Recent research has also highlighted the clinical value of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with its application for @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@) treatment, reducing @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@GDM@@@ and @DISEASE_Hypertension_Pregnancy_Induced @DISEASE_MESH:D046110 @@@gestational hypertension syndrome@@@ risk along with @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriage@@@ rate in early pregnancy; however, there is no clear consensus regarding the efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment in pregnant @SPECIES_9606 @@@women@@@ with @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@GDM@@@ pertaining to its effects on @DISEASE_Congenital_Abnormalities @DISEASE_MESH:D000013 @@@fetal malformation@@@, long-term growth and development of offspring, @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ in pregnant @SPECIES_9606 @@@women@@@, and maternal and infant outcomes. ", "citations": {"NLM": "Ouyang H, Al-Mureish A, Wu N. Research progress of metformin in gestational diabetes mellitus: a narrative review. Ann Palliat Med. 2021 Mar;10(3):3423-3437. PMID: 33849126", "BibTeX": "@article{33849126, title={Research progress of metformin in gestational diabetes mellitus: a narrative review.}, author={Ouyang H and Al-Mureish A and Wu N}, journal={Ann Palliat Med}, volume={10}, number={3}, pages={3423-3437}}"}}, {"_id": "40441707", "pmid": 40441707, "title": "Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment.", "journal": "Hum Reprod", "authors": ["Albert AB", "Corachán A", "Juárez-Barber E", "Cozzolino M", "Pellicer A", "Alecsandru D", "Cervelló I", "Ferrero H"], "date": "2025-05-29T00:00:00Z", "doi": "10.1093/humrep/deaf100", "meta_date_publication": "2025 May 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50248.434, "text_hl": "Alternatively, @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@IR@@@ @SPECIES_9606 @@@patients@@@ exposed to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ had a higher risk of clinical pregnancy [53.9% vs 35.9%; aRR = 1.467 (1.137-1.892) P = 0.003], lower risk of clinical @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriage@@@ [13.7% vs 26.3%; aRR = 0.481 (0.288-0.804), P = 0.005], and higher live birth rates [40.2% vs 9.6%; aRR = 4.069 (2.445-6.774), P < 0.001] than unexposed @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@IR@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Albert AB, Corachán A, Juárez-Barber E, Cozzolino M, Pellicer A, Alecsandru D, Cervelló I, Ferrero H. Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment. Hum Reprod. 2025 May 29;():. PMID: 40441707", "BibTeX": "@article{40441707, title={Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment.}, author={Albert AB and Corachán A and Juárez-Barber E and Cozzolino M and Pellicer A and Alecsandru D and Cervelló I and Ferrero H}, journal={Hum Reprod}}"}}, {"_id": "36058943", "pmid": 36058943, "title": "Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis.", "journal": "Arch Gynecol Obstet", "authors": ["Matorras R", "Pijoan JI", "Laínz L", "Díaz-Nuñez M", "Sainz H", "Pérez-Fernandez S", "Moreira D"], "date": "2022-09-04T00:00:00Z", "doi": "10.1007/s00404-022-06757-0", "meta_date_publication": "2022 Sep 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.812, "text_hl": "RESULTS: In @DISEASE_Paroxysmal_ventricular_fibrillation @DISEASE_MESH:C537182 @@@IVF@@@ pregnancies the risk of @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriage@@@ was significantly increased when considering @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriages@@@ in total (RR = 1.59; CI = 1.45-1.75), preclinical @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriages@@@ (RR = 1.59; CI = 1.35-1.88), and early @<m>DISEASE_Abortion_Spontaneous</m> @DISEASE_MESH:D000022 @@@miscarriages@@@ (RR = 1.44; CI = 1.16-1.79). ", "citations": {"NLM": "Matorras R, Pijoan JI, Laínz L, Díaz-Nuñez M, Sainz H, Pérez-Fernandez S, Moreira D. Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis. Arch Gynecol Obstet. 2022 Sep 4;():. PMID: 36058943", "BibTeX": "@article{36058943, title={Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis.}, author={Matorras R and Pijoan JI and Laínz L and Díaz-Nuñez M and Sainz H and Pérez-Fernandez S and Moreira D}, journal={Arch Gynecol Obstet}}"}}]}